KENYON LAWRENCE A

CIK 00012304845 companiesISELIN, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001230484

Recent Transactions

48 trades

Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2026-08-14+101,010→ 106,956 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2026-08-14+101,010→ 101,010 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2026-07-21+210,078→ 210,078 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2024-09-26$5.69/sh+5,000→ 5,946 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-03-20+12,500→ 12,500 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2021-04-20$1.83/sh+10,000→ 18,926 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-10-01+3,668,984→ 3,668,984 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-07-17+450,000→ 450,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-03-19+216,435→ 216,435 total
Sale
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-09-18$1.70/sh−1,350→ 8,926 total
Sale
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-09-18$1.70/sh−1,350→ 80,863 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2019-09-12+450,000→ 450,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2019-02-19+800,000→ 800,000 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-02-07$0.90/sh+25,000→ 82,213 total
Sale
Outlook Therapeutics, Inc.$OTLK
Common Stock
2018-09-18$0.87/sh−10,100→ 57,213 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2018-08-01+500,000→ 500,000 total
Sale
Outlook Therapeutics, Inc.$OTLK
Common Stock
2017-12-22$1.13/sh−26,165→ 67,313 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2016-12-21+50,000→ 93,478 total
Award
Arno Therapeutics, Inc
Stock Option (right to buy)
2014-02-24+223,445→ 223,445 total
Award
TAMIR BIOTECHNOLOGY, INC.
Common Stock (Right to Buy)
2012-07-23+400,000→ 400,000 total
Tax Payment
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-08-02$26.90/sh−6,312→ 14,337 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.19/sh−700→ 38,127 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.19/sh−4,711→ 33,416 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.20/sh−500→ 32,916 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.20/sh−2,800→ 30,116 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.20/sh−2,700→ 27,416 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.21/sh−100→ 27,316 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.21/sh−100→ 27,216 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.21/sh−1,041→ 26,175 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.21/sh−200→ 25,975 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.22/sh−200→ 25,775 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.22/sh−3,426→ 22,349 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.25/sh−100→ 22,149 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.25/sh−600→ 21,549 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.26/sh−400→ 21,149 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.27/sh−300→ 20,849 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.27/sh−200→ 20,649 total
Exercise/Conversion
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock, Option to Buy
2010-03-03−21,439→ 64,319 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.24/sh−100→ 22,249 total
Exercise/Conversion
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$13.06/sh+21,439→ 42,088 total
Sale
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-03-03$25.18/sh−3,261→ 38,827 total
Tax Payment
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-01-08$25.88/sh−897→ 20,649 total
Award
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2010-01-04+10,826→ 21,546 total
Award
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock, Option to Buy
2010-01-04+21,653→ 21,563 total
Award
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock, Option to Buy
2010-01-04+21,653→ 21,653 total
Award
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock, Option to Buy
2009-01-08+85,758→ 85,758 total
Award
PAR PHARMACEUTICAL COMPANIES, INC.
Common Stock
2009-01-08+10,720→ 10,720 total
Award
NEOPHARM INC
Common
2005-04-28$7.95/sh+43,100→ 43,100 total

Companies

Recent Filings

Address

C/O OUTLOOK THERAPEUTICS, INC. 111 S. WOOD AVE, UNIT #100

ISELIN, NJ, 08830

View on SEC.gov